ClinicalTrials.gg
RecruitingNCT07555496SPIN-NEEDUpdated Sep 11, 2026

A Comparative Study of Erector Spinae Fascia (ESF) Injection and Dry Needling Combined With Functional Rehabilitation (FR) in Patients With Chronic Low Back Pain Who Have Undergone Spinal Surgery (SPIN-NEED)

An interventional study of infiltration of the erector spinae fascia and Dry needling in Back Pain Lower Back Chronic, sponsored by Clinique de la Côte d'Emeraude. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-11.

Sponsored by Clinique de la Côte d'Emeraude · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 114 studies in Low Back Pain with a site in France — 30 open to participants now, 33 under way, 5 of them phase 3. Low Back Pain · France.

Planned enrollment
28th of 79
120 · median 82
Started
2026
with 10 others
No phase
61 of 114
21 open now
Primary completion
2028-12
later than 32 of 32 live
Registered
109th of 114
by date

Among the 114 studies in Low Back Pain with a site in France, this one is the 28th largest by planned enrollment of the 79 interventional ones that give a count, is one of 11 that started in 2026, is one of 61 with no phase, reaches primary completion later than 32 of the 32 other live ones, and was the 109th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

30 of the 114 studies in Low Back Pain with a site in France are open now. Recruiting first, the newest first:

24 more — sign in →

All 30 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 114 studies in Low Back Pain with a site in France, or all of them as a file.
02

Study summary

Chronic low back pain represents a major public health issue, with an estimated prevalence of up to 23% in the adult population and a significant impact on quality of life and functional capacity. Among these patients, a significant proportion undergo spinal surgery-including laminectomy, discectomy, or spinal fusion-when conservative treatment has failed to provide adequate relief. Current treatment strategies involve functional spinal rehabilitation (FSR). Due to the multifaceted and complex pathophysiology of this chronic pain condition, we have previously addressed the spinal syndrome in terms of its functional and muscular component: the myofascial expression. In our clinical practice, we have introduced a minimally invasive paravertebral procedure, guided by ultrasound, targeting the fascia of the erector spinae muscles in the lower lumbar region. The goal of this procedure is to provide pain relief to the patient, enabling them to better adhere to the rehabilitative treatment (functional restoration of the spine) and ultimately improve the patient's quality of life within their environment. This evaluation of professional practices highlights a clear clinical indication in favor of infiltration of the erector spinae fascia, with a significant majority of patients reporting improved pain relief and better adherence to rehabilitation.

Thus, within a coordinated, multidisciplinary care approach, this intervention appears to address patient expectations regarding comfort and leads us to consider the myofascial component of the complaint. The proposed paravertebral intervention is also appropriate in accordance with the updated recommendations, which are very restrictive in the context of a surgically treated spine (PSPS-2). This assessment of current practices justifies the implementation of a prospective controlled study. Through this study, we aim to investigate the treatment's effects and evaluate its pharmacological (via the anti-inflammatory action of corticosteroids) and mechanical (via needle-induced muscle stimulation) components.

03

Conditions studied

  • Back Pain Lower Back Chronic

Browse trials for

Keywords

  • chronic back pain
  • infiltration
  • epineurium of the erector spinae muscles
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient with chronic back pain, with previous surgery

Exclusion criteria

Exclusion Criteria:

  • Patients with specific or common low back pain
  • Patients receiving posterior subcutaneous spinal cord stimulation
  • Patients with a of less than 12 months
  • Patients with a to injections (coagulation disorder)
  • Pregnant or breastfeeding patients
  • Patients with cognitive and/or psychobehavioral disorders
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
120 participants (estimated)

Study arms

  • Placebo comparator
    spinal rehabilitation + placebo

    Procedure: Placebo

  • Sham comparator
    spinal rehabilitation + dry needling

    Procedure: Dry needling

  • Experimental
    spinal rehabilitation + infiltration

    Procedure: infiltration of the erector spinae fascia

Interventions

  • Procedureinfiltration of the erector spinae fascia

    Injection of half a vial of Diprostene 1.5 mL + Lidocaine 1.5 mL-under ultrasound guidance-targeting the erector spinae muscles medial to the posterior superior iliac spine-bilaterally

  • ProcedureDry needling

    Dry needle insertion guided by ultrasound, with manipulation targeting the spinal erector muscles medial to the posterior superior iliac spine-on both sides.

  • ProcedurePlacebo

    simulated procedure (non-invasive puncture with a stylet in the lower lumbar region, medial to the posterior superior iliac spine-on both sides).

06

What researchers measure

Primary outcomes

  1. Change in lumbar functional disability

    assessed by Oswestry disability index (ODI)

    Time frame: between day 0 (intervention) and 3 months after intervention

Secondary outcomes

  1. Pain evaluation

    Assessed by visual analogic scale (VAS) for pain, from 0 (no pain) to 10 (worst pain)

    Time frame: day 0, 1 month, 3 months

  2. Quality of life evaluation

    Measured by Study Questionnaire Short Form 36 Health Survey (SF-36) : The SF-36 has eight scaled scores; the scores are weighted sums of the questions in each section. Scores range from 0 - 100 (Lower scores = more disability, higher scores = less disability)

    Time frame: Day 0, 1 month, 3 months

  3. lumbar function evaluation

    muscle and functional performance measured using metrological score SHIRADO ITO

    Time frame: Day 0, 1 month, 3 months

  4. Measuring the patient's avoidance behaviors

    Assessed by Fear Avoidance Belief Questionnaire (FABQ) : The complete FABQ is administered as a single 16-item questionnaire. Patients rate each item on a 7-point scale: 0 = completely disagree, 6 = completely agree.

    Time frame: Day 0, 1 month, 3 months

07

Study locations

1 of 1 sites recruiting
  • Emerald Coast Clinic
    St-Malo, 35400, France
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Dec 2028, 27 months after the start.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 27 months is above that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 21, 2026
First posted
Apr 29, 2026
StartActual
Sep 7, 2026
Primary completionEst.
Dec 31, 2028
CompletionEst.
Mar 31, 2029
Last update
Sep 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07555496
Lead sponsor
Clinique de la Côte d'Emeraude
Responsible party
Sponsor
First posted
Apr 29, 2026
Start date
Sep 7, 2026
Primary completion
Dec 31, 2028 (estimated)
Completion
Mar 31, 2029 (estimated)
Last update
Sep 11, 2026

Study contacts

Marion Mandon, PhD
Contact
mmandon@vivcalto-sante.com
+33 6 78 27 76 72
Julien Baglione-Streliski, MD
principal investigator · Emerald Coast Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion